España
India
Italia
대한민국
日本
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
India
Italia
대한민국
日本
  • Our Services
  • News
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Legal
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Forex
    Cannabis
    Commodities
    Binary Options
    Bonds
    Futures
    CME Group
    Global Economics
    Mining
    Previews
    Small-Cap
    Real Estate
    Penny Stocks
    Digital Securities
    Volatility
  • Options
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    From The Press
    Jim Cramer
    Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
  • Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks

Steven Lichtman


Penumbra Is Poised For Growth As Blood Clot Awareness Rises: Analyst
Oppenheimer: After FDA Approval Of Tandem's Insulin Pump, Investor Focus Will Shift To 2018 Opportunities
Oppenheimer Previews Medtronic's Q4 Earnings, Remains Bullish
Oppenheimer: After FDA Approval Of Tandem's Insulin Pump, Investor Focus Will Shift To 2018 Opportunities
Oppenheimer Previews Medtronic's Q4 Earnings, Remains Bullish
35 Stock Ideas Oppenheimer Analysts Love Right Now
This Analyst Sees 25% Upside in Medtronic

35 Stock Ideas Oppenheimer Analysts Love Right Now
This Analyst Sees 25% Upside in Medtronic
Oppenheimer Reiterates Rating, Lowers Price Target On Insulet As New Management Begins Executing Plan
UPDATE: Oppenheimer Raises PT On Globus Medical On Pre-Announced 4Q14 Revenue
Read More...

Steven Lichtman Recent News

Oppenheimer's 5 Highlights From Medtronic's Analyst Day
UPDATE: Oppenheimer Initiates Coverage on InspireMD on Novel Solution for STEMI
UPDATE: Oppenheimer Initiates Sunshine Heart at Outperform on C-Pulse Potential
UPDATE: Oppenheimer Initiates Volcano at Outperform on Multiple Positive Factors
UPDATE: Oppenheimer Raises PT on Globus Medical Following Close of Patent Infringement Case
Oppenheimer Reiterates Outperform Rating on Endologix Following Management Meetings
UPDATE: Oppenheimer Raises PT on Medtronic Following Solid FQ4 Sales

Connect With Us

facebookinstagramlinkedintwitteryoutube

About Benzinga

  • About Us
  • Careers
  • Advertise
  • Contact Us

Market Resources

  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets

Trading Tools & Education

  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investors Events
  • Pre market Stock Analysis and News
  • Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2025 Benzinga | All Rights Reserved